Plasma Thiamine Deficiency Associated with Alzheimer's Disease but Not Parkinson's Disease

被引:0
|
作者
Michael Gold
Robert A. Hauser
Marianne F. Chen
机构
[1] University of South Florida College of Medicine,Department of Neurology
[2] University of South Florida College of Medicine,Department of Internal Medicine
[3] University of South Florida College of Medicine,Department of Neurology
来源
Metabolic Brain Disease | 1998年 / 13卷
关键词
Alzheimer's Disease; Parkinson's Disease; Thiamine; Dementia;
D O I
暂无
中图分类号
学科分类号
摘要
In this study we compared plasma and erythrocyte thiamine levels in a group of patients with idiopathic Parkinson's Disease (iPD) to a group of patients with probable Alzheimer's Disease (pAD). pAD patients had significantly lower plasma thiamine levels (raw and z-score) than iPD patients. A significantly higher number of pAD patients had plasma thiamine deficiencies than iPD patients. The demographics of our patient groups were similar to those reported by other investigators, making age, sex and nutritional status unlikely explanations for our findings. These results suggest that plasma thiamine deficiency is associated with pAD but not with iPD.
引用
收藏
页码:43 / 53
页数:10
相关论文
共 50 条
  • [1] Plasma thiamine deficiency associated with Alzheimer's disease but not Parkinson's disease
    Gold, M
    Hauser, RA
    Chen, MF
    METABOLIC BRAIN DISEASE, 1998, 13 (01) : 43 - 53
  • [2] Subclinical Zinc Deficiency in Alzheimer's Disease and Parkinson's Disease
    Brewer, George J.
    Kanzer, Steve H.
    Zimmerman, Earl A.
    Molho, Eric S.
    Celmins, Dzintra F.
    Heckman, Susan M.
    Dick, Robert
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2010, 25 (07): : 572 - 575
  • [3] Thiamine and Parkinson's disease
    Khanh Vinh Quoc Luong
    Lan Thi Hoang Nguyen
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 316 (1-2) : 1 - 8
  • [4] Plasma Alzheimer's disease biomarkers and cognitive progression in Parkinson's disease
    Pilotto, A.
    Ashton, N. J.
    Lupini, A.
    Battaglio, B.
    Gipponi, S.
    Cottini, E.
    Grossi, I.
    Salvi, A.
    de Petro, G.
    Pizzi, M.
    Blennov, K.
    Gonzalez, M.
    Aarsland, D.
    Zetterberg, H.
    Padovani, A.
    MOVEMENT DISORDERS, 2022, 37 : S546 - S547
  • [5] Biomonitoring of mycotoxins in the plasma of patients with Alzheimer's disease and Parkinson's disease
    Souques, Martine
    ENVIRONNEMENT RISQUES & SANTE, 2022, 21 (03): : 249 - 250
  • [6] Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease
    Lim, Nicholas S.
    Swanson, Christine R.
    Cherng, Hua-Ren
    Unger, Travis L.
    Xie, Sharon X.
    Weintraub, Daniel
    Marek, Ken
    Stern, Matthew B.
    Siderowf, Andrew
    Trojanowski, John Q.
    Chen-Plotkin, Alice S.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (05): : 346 - 355
  • [7] Cholinergic deficiency in Alzheimer's and Parkinson's disease: Evaluation with pupillometry
    Fotiou, D. F.
    Stergiou, V.
    Tsiptsios, D.
    Lithari, C.
    Nakou, M.
    Karlovasitou, A.
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2009, 73 (02) : 143 - 149
  • [8] Role of Thiamine in Alzheimer's Disease
    Khanh Vinh Quo'c Lu'o'ng
    Lan Thi Hoang Nguyen
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2011, 26 (08): : 588 - 598
  • [9] Thiamine therapy in Alzheimer's disease
    Mimori, Y
    Katsuoka, H
    Nakamura, S
    METABOLIC BRAIN DISEASE, 1996, 11 (01) : 89 - 94
  • [10] Iron in Alzheimer's disease and Parkinson's disease
    Bush, A.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 5 - 5